Correction to: Overall survival analysis in patients with metastatic breast cancer and liver or lung metastases treated with eribulin, gemcitabine, or capecitabine
- PMID: 33907908
- PMCID: PMC8496657
- DOI: 10.1007/s10549-021-06223-6
Correction to: Overall survival analysis in patients with metastatic breast cancer and liver or lung metastases treated with eribulin, gemcitabine, or capecitabine
Erratum for
-
Overall survival analysis in patients with metastatic breast cancer and liver or lung metastases treated with eribulin, gemcitabine, or capecitabine.Breast Cancer Res Treat. 2020 Nov;184(2):559-565. doi: 10.1007/s10549-020-05867-0. Epub 2020 Aug 17. Breast Cancer Res Treat. 2020. PMID: 32808239 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
